What others are saying
- No events
ActiveCare® is a trademark brand of MCS. It is an effective and safe DVT prevention with no major bleeding, for patients undergoing knee or hip replacement surgery.
ActiveCare® fully meets the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (ACCP) 2012, to prevent DVT after Total Joint Replacement for the whole duration of treatment from hospital to home.
ActiveCare® is an economically viable DVT prevention. It minimizes the occurrence of major bleeding complications, that are associated with the use of anticoagulants, that may lead to costly readmissions.
ActiveCare® is currently used in more than 80 surgical centers across the US, daily. With over 100,000 patients so far and numerous clinical studies ActiveCare® has gained impressive clinical outcomes.
ActiveCare® line of products are cleared for market in the US, EU, Korea, Japan, Israel and Australia.
IBD Consulting provides complete business development services for leading-edge companies wishing to enter new and emerging markets. From initial consultation and market appraisals, to establishing your solution in your target market, we can assist your company in achieving its international business development goals. At IBD Consulting we choose to work with companies using innovative technologies in the medical, agri and hi-tech sectors, with a focus on companies coming from and seeking entry into the Israeli, Australian and New Zealand markets.